82 related articles for article (PubMed ID: 16188687)
1. Acute promyelocytic leukemia: a model of molecular target based therapy.
Zhou GB; Chen SJ; Chen Z
Hematology; 2005; 10 Suppl 1():270-80. PubMed ID: 16188687
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
3. Acute promyelocytic leukemia: a paradigm for differentiation therapy.
Grimwade D; Mistry AR; Solomon E; Guidez F
Cancer Treat Res; 2010; 145():219-35. PubMed ID: 20306254
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy: The new lease on life for acute promyelocytic leukemia, and beyond.
Chen SJ; Zhou GB
IUBMB Life; 2012 Aug; 64(8):671-5. PubMed ID: 22714999
[TBL] [Abstract][Full Text] [Related]
5. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
Vitoux D; Nasr R; de The H
Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
[TBL] [Abstract][Full Text] [Related]
6. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia.
Zhang P
J Biol Regul Homeost Agents; 1999; 13(4):195-200. PubMed ID: 10703942
[TBL] [Abstract][Full Text] [Related]
7. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
8. How to manage acute promyelocytic leukemia.
Mi JQ; Li JM; Shen ZX; Chen SJ; Chen Z
Leukemia; 2012 Aug; 26(8):1743-51. PubMed ID: 22422168
[TBL] [Abstract][Full Text] [Related]
9. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
Quezada G; Kopp L; Estey E; Wells RJ
Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
[TBL] [Abstract][Full Text] [Related]
10. A single course of all-trans retinoic acid plus arsenic trioxide reached a long-term survival in a patient with newly diagnosed acute promyelocytic leukemia: a suggestion for reduction of treatment courses?
Yan J; Chen X; Shao J
Eur J Haematol; 2013 Nov; 91(5):470-1. PubMed ID: 23869721
[No Abstract] [Full Text] [Related]
11. Triple A therapy: the molecular underpinnings of the unique sensitivity of leukemic promyelocytes to anthracyclines, all-trans-retinoic acid and arsenic trioxide.
Nichol JN; Garnier N; Miller WH
Best Pract Res Clin Haematol; 2014 Mar; 27(1):19-31. PubMed ID: 24907014
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy.
Park JH; Tallman MS
Oncology (Williston Park); 2011 Jul; 25(8):733-41. PubMed ID: 21874835
[TBL] [Abstract][Full Text] [Related]
13. Advanced progress on the relationship between RA and its receptors and malignant tumors.
Li M; Sun Y; Guan X; Shu X; Li C
Crit Rev Oncol Hematol; 2014 Sep; 91(3):271-82. PubMed ID: 24793539
[TBL] [Abstract][Full Text] [Related]
14. From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies: leukemia research in the genomic era.
Zhou GB; Li G; Chen SJ; Chen Z
Acta Pharmacol Sin; 2007 Sep; 28(9):1434-49. PubMed ID: 17723177
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances of differentiation-inducing therapy for leukemia].
Kizaki M
Rinsho Ketsueki; 2000 Mar; 41(3):173-6. PubMed ID: 10774243
[No Abstract] [Full Text] [Related]
16. What is the role of arsenic in newly diagnosed APL?
Tallman MS
Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
[TBL] [Abstract][Full Text] [Related]
17. Differentiation therapy in acute promyelocytic leukemia: European experience.
Degos L
J Cell Physiol; 1997 Nov; 173(2):285-7. PubMed ID: 9365538
[TBL] [Abstract][Full Text] [Related]
18. Two cases of therapy-related acute promyelocytic leukemia (t-APL) after mantle cell lymphoma and gestational trophoblastic disease.
Au WY; Ma SK; Chung LP; Chim CS; Kwong YL
Ann Hematol; 2002 Nov; 81(11):659-61. PubMed ID: 12454706
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid.
Tong H; Li K; Mei C; Wang H; Chen Z; Jin J
Ann Hematol; 2011 Dec; 90(12):1493-4. PubMed ID: 21431323
[No Abstract] [Full Text] [Related]
20. Evidence for basophilic differentiation of acute promyelocytic leukaemia cells during arsenic trioxide therapy.
Masamoto Y; Nannya Y; Arai S; Koike Y; Hangaishi A; Yatomi Y; Kurokawa M
Br J Haematol; 2009 Mar; 144(5):798-9. PubMed ID: 19036092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
